Effect of chronic interleukin-2 treatment on RES phagocytic activity in the rat.
The effect of chronic interleukin-2 (IL-2) injection upon reticuloendothelial system (RES) function in the rat has been determined. Seven-day treatments with two doses of human recombinant IL-2 resulted in a dramatic reduction in the phagocytic uptake of the liver and spleen, while increasing the weight of both organs. There were dramatic histological changes in the intestine, liver and spleen as well. These results suggest that the chronic use of IL-2 can result in hepatic dysfunction, which is associated with altered RES phagocytic function.
Trop
M
M
Department of Pediatrics, Massachusetts General Hospital, Boston.
Anderson
T D
TD
Schiffrin
E J
EJ
Carter
E A
EA
D000818:Animals; D007376:Interleukin-2 / Q000494:pharmacology*; D007422:Intestines / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D012157:Mononuclear Phagocyte System / Q000187:drug effects* / Q000502:physiology; D009929:Organ Size / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects*; D051381:Rats; D013154:Spleen / Q000187:drug effects / Q000503:physiopathology
D007376:Interleukin-2